4/3
04:46 pm
alur
Allurion Announces Postponement of Special Meeting of Stockholders [Yahoo! Finance]
Medium
Report
Allurion Announces Postponement of Special Meeting of Stockholders [Yahoo! Finance]
4/3
04:30 pm
alur
Allurion Announces Postponement of Special Meeting of Stockholders
Medium
Report
Allurion Announces Postponement of Special Meeting of Stockholders
3/27
08:15 am
alur
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Medium
Report
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
3/26
08:13 am
alur
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
3/26
08:00 am
alur
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Low
Report
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
3/21
10:29 am
alur
Allurion Technologies Inc. (NYSE: ALUR) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $16.00 price target on the stock.
High
Report
Allurion Technologies Inc. (NYSE: ALUR) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $16.00 price target on the stock.
3/21
08:09 am
alur
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
Medium
Report
Allurion Technologies Inc. (NYSE: ALUR) had its "neutral" rating re-affirmed by analysts at Chardan Capital. They now have a $2.50 price target on the stock.
3/20
04:19 pm
alur
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence [Yahoo! Finance]
High
Report
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence [Yahoo! Finance]
3/20
04:05 pm
alur
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
High
Report
Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence
3/12
04:05 pm
alur
Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025
Medium
Report
Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025
3/4
04:05 pm
alur
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
High
Report
Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity
2/25
04:05 pm
alur
Allurion to Participate in Upcoming Investor Conferences
Medium
Report
Allurion to Participate in Upcoming Investor Conferences
2/20
04:05 pm
alur
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
Low
Report
Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
2/19
09:03 am
alur
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
High
Report
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline
2/18
08:40 am
alur
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity [Yahoo! Finance]
Medium
Report
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity [Yahoo! Finance]
2/18
08:30 am
alur
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity
Medium
Report
Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity
2/13
08:54 am
alur
Allurion Relaunches in France [Yahoo! Finance]
Low
Report
Allurion Relaunches in France [Yahoo! Finance]
2/13
08:30 am
alur
Allurion Relaunches in France
Low
Report
Allurion Relaunches in France
2/10
11:48 am
alur
How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67% [Yahoo! Finance]
Low
Report
How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67% [Yahoo! Finance]
1/23
03:48 pm
alur
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
High
Report
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
1/21
08:30 am
alur
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
High
Report
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
1/14
09:18 am
alur
Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024
Medium
Report
Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024